HeartBeam (NASDAQ: BEAT) Tackles Heart Disease with Next-Generation ECG Solutions

Published May 6, 2026, 3:50 PM

Cardiovascular disease remains the leading cause of death in the United States.
One of the most persistent challenges in cardiac care is patient delay in seeking care.
HeartBeam is working to address this gap by transforming how ECG data are collected and used through its HeartBeam System.

Cardiovascular disease continues to be a major global health challenge, driven by aging populations, lifestyle factors and persistent gaps in early detection that continue to challenge healthcare systems. In response to these trends, HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored, positioning its solutions at the intersection of rising clinical need and evolving innovation.

The scale and severity of cardiac disease underscore the urgency of new approaches. According to the Centers for Disease Control and Prevention, cardiovascular disease remains the leading cause of death in the United States, accounting for more than 919,000 deaths in 2023, or roughly one in every…